Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Poison Ivy, Oak, and Sumac Dermatitis

What Is Known and What Is New?

Kim, Yesul, MD*; Flamm, Alexandra, MD*; ElSohly, Mahmoud A., PhD†‡; Kaplan, Daniel H., MD, PhD§; Hage, Raymond J. Jr, MBA; Hamann, Curtis P., MD; Marks, James G. Jr, MD*

doi: 10.1097/DER.0000000000000472

Poison ivy, poison oak, and poison sumac are the most common causes of clinically diagnosed allergic contact dermatitis in North America. Approximately 50% to 75% of the US adult population is clinically sensitive to poison ivy, oak, and sumac. We reviewed the botany and history of these plants; urushiol chemistry and pathophysiology, clinical features, and the prevalence of allergic contact dermatitis caused by these plants; and current postexposure treatment and preventive methods, including ongoing investigations in the development of a vaccine (immunotherapy). Although extensive efforts have been made to develop therapies that prevent and treat contact dermatitis to these plants, there lacks an entirely effective method, besides complete avoidance. There is a need for a better therapy to definitively prevent allergic contact dermatitis to these plants.

From the *Department of Dermatology, Penn State Hershey Medical Center, Hershey, PA;

National Center for Natural Products Research and Department of Pharmaceutics and Drug Delivery, University of Mississippi;

ElSohly Laboratories, Incorporated, Oxford, MS;

§Department of Dermatology, University of Pittsburgh, PA;

Hapten Sciences, Memphis, TN; and

Contact Dermatitis Institute, Phoenix, AZ.

Address reprint requests to: Yesul Kim, MD, 500 University Dr, PO Box 850, Hershey, PA 17033. E-mail:

J.G.M. is a consultant to Hapten Sciences, Inc.

© 2019 American Contact Dermatitis Society
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website